A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)

被引：0

作者：

Powles, T. B. ^{[1
]}

van der Heijden, M. S. ^{[2
]}

Galsky, M. D. ^{[3
]}

Al-Ahmadie, H. ^{[4
]}

Meeks, J. J. ^{[5
]}

Nishiyama, H. ^{[6
]}

Vu, T. Q. ^{[7
]}

Antonuzzo, L. ^{[8
]}

Wiechno, P. ^{[9
]}

Atduev, V. ^{[10
]}

Kann, A. G. ^{[11
]}

Kim, T-H. ^{[12
]}

Rodriguez, C. Suarez ^{[13
]}

Chang, C-H. ^{[14
,15
]}

Roghmann, F. ^{[16
]}

Ozguroglu, M. ^{[17
]}

Armstrong, J. ^{[18
]}

Ho, S. ^{[19
]}

Hois, S. ^{[19
]}

Catto, J. ^{[20
,21
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Genitourinary Oncol, London, England

[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[3] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, New York, NY USA

[5] Northwestern Univ, Feinberg Sch Med, Dept Urol Biochem & Mol Genet, Chicago, IL USA

[6] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan

[7] Vietnam Natl Canc Hosp, Dept Internal Med 3, Hanoi, Vietnam

[8] Univ Careggi, Azienda Osped, SODc Oncol Med, Florence, Italy

[9] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Urooncol, Warsaw, Poland

[10] Fed Med Biol Agcy, Volga Dist Med Ctr, Nizhnii Novgorod, Russia

[11] Hosp Alemao Oswaldo Cruz, Oncol Clin, Sao Paulo, Brazil

[12] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea

[13] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Med Oncol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain

[14] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan

[15] China Med Univ & Hosp, Sch Med, Taichung, Taiwan

[16] Ruhr Univ Bochum, Marien Hosp, Univ Hosp, Dept Urol, Herne, Germany

[17] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Internal Med, Istanbul, Turkey

[18] AstraZeneca, Stat, Cambridge, England

[19] AstraZeneca, Oncol, Gaithersburg, MD USA

[20] Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England

[21] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.2327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA5

引用

页码：1271 / 1271

页数：1

共 50 条

[31] Neoadjuvant chemoradiotherapy followed by radical cystectomy for muscle-invasive bladder cancer: Efficacy and feasibility in 119 patients
Fujiwara, M.
Tanaka, H. T.
Asai, S. A.
Maezawa, Y. M.
Aida, Y. A.
Chen, W. C.
Yoshitomi, K. Y.
Soma, T. S.
Kobayashi, M. K.
Nakamura, Y. N.
Fan, B. F.
Ishikawa, Y. I.
Fukuda, S. F.
Yoshida, S. Y.
Yokoyama, M. Y.
Fujii, Y. F.
EUROPEAN UROLOGY, 2023, 83
[32] Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC.
Lee, Jiyun
Cho, Jaeho
Lee, Chang
Lee, Chang Young
Lee, Jin Gu
Kim, Dae Joon
Shim, Hyo Sup
Lim, Sun Min
Kim, Hye Ryun
Cho, Byoung Chul
Hong, Min Hee
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] Durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer: Preliminary results from the Bladder Cancer Signal Seeking Trial (BLASST)-2
Wei, Xiao X.
McGregor, Bradley Alexander
Lee, Richard J.
Gao, Xin
Kilbridge, Kerry L.
Preston, Mark A.
Mossanen, Matthew
Ingham, Matthew D.
Steele, Graeme S.
Klein, Alyssa
Van Allen, Eliezer Mendel
Severgnini, Mariano
Giannakis, Marios
Sonpavde, Guru
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[34] Muscle-Invasive Bladder Cancer and Radical Cystectomy
Hakenberg, Oliver W.
EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (01) : 1 - 1
[35] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
Matsubara, Nobuaki
Mukai, Hirofumi
Naito, Yoichi
Nezu, Masahiko
Itoh, Kuniaki
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 310 - 317
[36] A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer - Comment
Scher, HI
JOURNAL OF UROLOGY, 1996, 155 (02): : 499 - 500
[37] A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Meeks, Joshua J.
Bellmunt, Joaquim
Bochner, Bernard H.
Clarke, Noel W.
Daneshmand, Siamak
Galsky, Matthew D.
Hahn, Noah M.
Lerner, Seth P.
Mason, Malcolm
Powles, Thomas
Sternberg, Cora N.
Sonpavde, Guru
EUROPEAN UROLOGY, 2012, 62 (03) : 523 - 533
[38] Review of Current Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Houede, Nadine
Pourquier, Philippe
Beuzebo, Philippe
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (03) : E20 - E25
[39] COST-EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY REGIMENS PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
Joyce, Daniel D.
Wymer, Kevin M.
Sharma, Vidit
Moriarty, James P.
Borah, Bijan J.
Geynisman, Daniel M.
Plimack, Elizabeth R.
Costello, Brian A.
Pagliaro, Lance C.
Boorjian, Stephen A.
JOURNAL OF UROLOGY, 2022, 207 (05): : E670 - E671
[40] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
Murasawa, Hiromi
Koie, Takuya
Ohyama, Chikara
Yamamoto, Hayato
Imai, Atsushi
Hatakeyama, Shingo
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Iwabuchi, Ikuya
Ogasawara, Masaru
Kawaguchi, Toshiaki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 159 - 165

← 1 2 3 4 5 →